Pharmabiz12m
Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study
Cipher Pharma announces Moberg Pharma’s nail fungus treating product MOB-015 fails to meet primary endpoint in phase 3 study: Mississauga Thursday, December 12, 2024, 18:00 Hrs ...
Pharmabiz33m
FIP releases new skills reference guide focuses on pharmacists supporting self-care for Universal Health Coverage Day
FIP releases new skills reference guide focuses on pharmacists supporting self-care for Universal Health Coverage Day: Our Bureau, Bengaluru Thursday, December 12, 2024, 17:40 Hrs ...
Pharmabiz42m
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India
MannKind and Cipla announce CDSCO approves Afrezza inhalation powder in India: Our Bureau, Mumbai Thursday, December 12, 2024, 17:30 Hrs [IST] MannKind Corporation, a company focu ...